rs7025577

Positions:

• chr9-114899385-C-A
• chr9-114899385-C-G
• chr9-114899385-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001252290.1(TNFSF8):​c.409+4842G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.565 in 147,604 control chromosomes in the GnomAD database, including 25,402 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.56 (25402 hom., cov: 24)
• Consequence: TNFSF8 NM_001252290.1 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -1.61

Genes affected

TNFSF8 (HGNC:11938): (TNF superfamily member 8) The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF8/CD30, which is a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. The engagement of this cytokine expressed on B cell surface plays an inhibitory role in modulating Ig class switch. This cytokine was shown to enhance cell proliferation of some lymphoma cell lines, while to induce cell death and reduce cell proliferation of other lymphoma cell lines. The pleiotropic biologic activities of this cytokine on different CD30+ lymphoma cell lines may play a pathophysiologic role in Hodgkin's and some non-Hodgkin's lymphomas. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]

DELEC1 (HGNC:23658): (deleted in esophageal cancer 1) The function of this gene is not known. This gene is located in a region commonly deleted in esophageal squamous cell carcinomas. Gene expression is reduced or absent in these carcinomas and thus this is a candidate tumor suppressor gene for esophageal squamous cell carcinomas. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.98).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
TNFSF8	NM_001252290.1	c.409+4842G>T		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
TNFSF8	ENST00000618336.4	c.409+4842G>T		intron_variant		3
TNFSF8	ENST00000474301.1	n.82+4842G>T		intron_variant, non_coding_transcript_variant		2
DELEC1	ENST00000648852.1	n.50-22065C>A		intron_variant, non_coding_transcript_variant
DELEC1	ENST00000649565.1	n.225+14077C>A		intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes AF: 0.564 AC: 83210 AN: 147496 Hom.: 25350 Cov.: 24

Gnomad AFR AF: 0.796

Gnomad AMI AF: 0.643

Gnomad AMR AF: 0.640

Gnomad ASJ AF: 0.459

Gnomad EAS AF: 0.400

Gnomad SAS AF: 0.449

Gnomad FIN AF: 0.486

Gnomad MID AF: 0.402

Gnomad NFE AF: 0.449

Gnomad OTH AF: 0.519

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.565 AC: 83326 AN: 147604 Hom.: 25402 Cov.: 24 AF XY: 0.567 AC XY: 40622 AN XY: 71660

Gnomad4 AFR AF: 0.797

Gnomad4 AMR AF: 0.641

Gnomad4 ASJ AF: 0.459

Gnomad4 EAS AF: 0.400

Gnomad4 SAS AF: 0.448

Gnomad4 FIN AF: 0.486

Gnomad4 NFE AF: 0.449

Gnomad4 OTH AF: 0.522

Alfa AF: 0.444 Hom.: 1696

Bravo AF: 0.593

Asia WGS AF: 0.516 AC: 1783 AN: 3470

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.98
CADD	Benign	0.040
DANN	Benign	0.62

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs7025577; hg19: chr9-117661665;